Philips receives FDA clearance for the use of its ultrasound portfolio to manage COVID-19-related lung and cardiac complications
Royal Philips, a global leader in health technology, announced that it has received 510 K clearance from the U.S. FDA to market a wide range of its ultrasound...
|